Looking for information about ENOBIA PHARMA HEADQUARTERS? Follow the links below to find all the information you are interested in. Addresses, telephones, emails, working hours and other useful information.


Enobia Pharma - Crunchbase Company Profile & Funding

    https://www.crunchbase.com/organization/enobia-pharma
    Medical. Founded Date 1997. Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. Contact Email [email protected]. Phone Number +1 203-272-2596. Enobia develops therapies to treat serious genetic bone …

Enobia Pharma LinkedIn

    https://www.linkedin.com/company/enobia-pharma
    Enobia Pharma 1,328 followers on LinkedIn. Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments. Our lead product in development, ENB-0040 ...

Enobia Pharma Company Profile: Acquisition & Investors ...

    https://pitchbook.com/profiles/company/52644-07
    Enobia Pharma General Information Description. Developer of therapies to treat genetic bone disorders for which there are no approved treatments. The company's products are used for the treatment of hypophosphatasia (HPP).

Enobia Pharma Inc. - Company Profile - BCIQ

    https://www.biocentury.com/companies/Enobia_Pharma_Inc
    Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more.

20120431: Alexion Pharmaceuticals, Inc.; Enobia Pharma ...

    https://www.ftc.gov/enforcement/premerger-notification-program/early-termination-notices/20120431
    The official website of the Federal Trade Commission, protecting America’s consumers for over 100 years.

Protocol - NEJM

    https://www.nejm.org/doi/suppl/10.1056/NEJMoa1106173/suppl_file/nejmoa1106173_protocol.pdf
    Enobia Pharma US Enobia Pharma Headquarters 245 First Street, Suite 1809 2901, Rachel Street East, Suite 23 Cambridge, MA 02142 Montreal, QC H1W4A4 Canada

Alexion Acquires Enobia Pharma For $1.1 Billion - Courant

    https://www.courant.com/business/hc-xpm-2012-02-08-hc-alexion-closes-enobia-deal-20120208-story.html
    Feb 08, 2012 · Alexion Pharmaceuticals Inc., a Cheshire biopharmaceutical company that develops treatments for rare disorders, has acquired Enobia Pharma Corp. …

Alexion to acquire Enobia Pharma for $610 ... - CenterWatch

    https://www.centerwatch.com/articles/21834
    Jan 03, 2012 · Alexion Pharmaceuticals and Enobia Pharma have signed a definitive agreement under which Alexion will acquire 100% of the capital stock of Enobia. Enobia is a private biopharmaceutical company based in Montreal, Canada and Cambridge, Massachusetts, which is focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.

In addition to information on ENOBIA PHARMA HEADQUARTERS, our site contains many other interesting information about corporate offices. We invite you to view the pages with related information.

Related Corporate Office Information: